|
Volumn 13, Issue 4, 2007, Pages 239-241
|
Angiotensin-converting enzyme inhibitor (ACE-I)- and angiotensin receptor blocker (ARB)-related angioedema: A neglected issue in daily practice in Greece
|
Author keywords
Adverse effects; Angioedema; Drugs; Primary care
|
Indexed keywords
ANGIOTENSIN RECEPTOR ANTAGONIST;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
ENALAPRIL;
LISINOPRIL;
QUINAPRIL;
RAMIPRIL;
VALSARTAN;
ADULT;
AGED;
ANGIONEUROTIC EDEMA;
CLINICAL ARTICLE;
CLINICAL PRACTICE;
CONTROLLED STUDY;
DRUG INFORMATION;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
FEMALE;
GREECE;
HOSPITAL ADMISSION;
HOSPITAL DISCHARGE;
HUMAN;
HYPERTENSION;
MALE;
MEDICAL AUDIT;
MEDICAL RECORD REVIEW;
OTORHINOLARYNGOLOGY;
PRIMARY MEDICAL CARE;
REVIEW;
SYMPTOM;
TELEPHONE;
TIME;
UNIVERSITY HOSPITAL;
AGE OF ONSET;
AGED;
ANGIOEDEMA;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
FEMALE;
GREECE;
HUMANS;
MALE;
MEDICAL AUDIT;
MIDDLE AGED;
PRIMARY HEALTH CARE;
RETROSPECTIVE STUDIES;
TIME FACTORS;
|
EID: 40649086971
PISSN: 13814788
EISSN: None
Source Type: Journal
DOI: 10.1080/13814780701627396 Document Type: Review |
Times cited : (2)
|
References (8)
|